Hi All,
This idea is about Natco Pharma
Fundamentals
Market Cap - 21712 Cr
Stock PE - 15
ROE - 25.9%
ROCE - 30%
Promoter Holding - 49.7
Quick Ratio - 3.42
D/E - 0.06
NATCO Pharma Limited (NATCO) is a vertically integrated, research and development focused pharmaceutical company engaged in developing, manufacturing, and marketing complex products for niche therapeutic areas.
Technicals
Since May 21, NATCO has formed a complete CUP and HANDLE formation on weekly chart and has now sustained the breakout for over 2 weeks. The earlier supply zone is now acting as demand zone indicating positive price action.
This is for mid/long term investors only
Hope you enjoy the idea,
Happy Trading,
Thanks,
Stock-n-Shine
This idea is about Natco Pharma
Fundamentals
Market Cap - 21712 Cr
Stock PE - 15
ROE - 25.9%
ROCE - 30%
Promoter Holding - 49.7
Quick Ratio - 3.42
D/E - 0.06
NATCO Pharma Limited (NATCO) is a vertically integrated, research and development focused pharmaceutical company engaged in developing, manufacturing, and marketing complex products for niche therapeutic areas.
Technicals
Since May 21, NATCO has formed a complete CUP and HANDLE formation on weekly chart and has now sustained the breakout for over 2 weeks. The earlier supply zone is now acting as demand zone indicating positive price action.
This is for mid/long term investors only
Hope you enjoy the idea,
Happy Trading,
Thanks,
Stock-n-Shine
עסקה פעילה
Gaining momentum after touching 10 SMAעסקה פעילה
3% up today, short term target is 1300Looking at its valuation, wouldn't be surprised if it reaches 1500 levels as well
עסקה פעילה
THIS HAS NOW BECOME A LONG TERM PICK BECAUSE OF FOLLOWING#NATCOPHARM (PE 15)
WONDER DRUG - gRevLimid (anti-cancer)
Natco's export formltions mk up 81% of its total rev. This segment grew 35% in Q4FY24, mainly due to its anti-cancer drug gRevlimid
Q1FY25 estimates
Revenue - 1608 Cr QoQ 50.6% YoY 41.1%
Net Profit - 753Cr QoQ 95% YoY 79.2%
With such valuations (PE 15) & moat it is poised for a good growth over several qtrs
עסקה פעילה
Great Stock, but learnt VP operations has resigned This might bring in some volatility in the stock
כתב ויתור
המידע והפרסומים אינם אמורים להיות, ואינם מהווים, עצות פיננסיות, השקעות, מסחר או סוגים אחרים של עצות או המלצות שסופקו או מאושרים על ידי TradingView. קרא עוד בתנאים וההגבלות.
כתב ויתור
המידע והפרסומים אינם אמורים להיות, ואינם מהווים, עצות פיננסיות, השקעות, מסחר או סוגים אחרים של עצות או המלצות שסופקו או מאושרים על ידי TradingView. קרא עוד בתנאים וההגבלות.